Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.059 million which missed the analyst consensus estimate of $2.309 million by 10.85 percent. This is a 2.23 percent increase over sales of $2.014 million the same period last year.